News

PARTNER I Trial TCT 2014 TAVR Heart Valve Repair

New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and...

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The...

BioControl Medical Enrollment INOVATE-HF Study CardioFit System Heart Failure

BioControl Medical announced that it has reached an important clinical trial milestone, reaching 480 randomized subjects — or 70 percent — of the planned 650 subjects with congestive...

September 16, 2014 — A quarter of adults in the United States have two or more chronic medical conditions, as do more than two-thirds of seniors, yet there are few clinical practice guidelines for...

Tryton Medical First U.S. Patient Extended Access Registry

Tryton Medical Inc. announced that the first patient in the United States has been enrolled in the Extended Access Registry, a single arm study of its Tryton Side Branch Stent. 

PressureWire St. Jude Medical Two-year FAME 2 Data FFR-guided PCI

St. Jude Medical Inc. announced primary outcome two-year data from the FAME 2 Trial, which demonstrated sustained superiority with FFR-guided PCI using St. Jude Medical PressureWire technology in...

Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

September 11, 2014 — Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they don’t fully understand how the...

Medtronic AdaptResponse Global Clinical Trial Cardiac Resynchronization Therapy

Medtronic Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes — including patient mortality and hospitalizations — in ...

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according...

Cook Medical Zilver PTX Drug Eluting Peripheral Stent Clinical Study China

Cook Medical has enrolled the first patient in the clinical study in China of its Zilver PTX Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investigators,...

Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online in the ...

A new analysis of clinical trial participation in the largest ongoing observational study of U.S. heart attack patients has found participants are not representative of the larger patient base,...

September 4, 2014 — St. Jude Medical announced a new multicenter clinical trial has found that using the company’s fractional flow reserve (FFR) technology changed the course of...

heart attack, JAMA, American Medical Association, acute coronary syndrome

In patients who experienced an acute coronary syndrome (ACS) event, use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 did not reduce the risk of recurrent...

September 3, 2014 — Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. The Cook Medical VIVO clinical research study aims to determine...

September 2, 2014 — Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-...

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and hypertension, according to research...

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online today in the...